Recruiting

Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

NCT06033287

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Hunan Cancer Hospital

Changsha, Hunan, China

Contact

Ning Xie, Dr.